Insights into Inhalation Drug Disposition: The Roles of Pulmonary Drug-Metabolizing Enzymes and Transporters

被引:3
|
作者
Dong, Liuhan [1 ]
Zhuang, Xiaomei [1 ]
机构
[1] Beijing Inst Pharmacol & Toxicol, Beijing 100850, Peoples R China
关键词
pulmonary pharmacokinetics; drug transporters; metabolizing enzymes; inhalation administration; ORGANIC CATION TRANSPORTERS; BRONCHIAL EPITHELIAL-CELLS; IN-VITRO METABOLISM; HUMAN LUNG; P-GLYCOPROTEIN; INHALED DRUG; RECEPTOR OCCUPANCY; RAT LUNG; EXPRESSION; VIVO;
D O I
10.3390/ijms25094671
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The past five decades have witnessed remarkable advancements in the field of inhaled medicines targeting the lungs for respiratory disease treatment. As a non-invasive drug delivery route, inhalation therapy offers numerous benefits to respiratory patients, including rapid and targeted exposure at specific sites, quick onset of action, bypassing first-pass metabolism, and beyond. Understanding the characteristics of pulmonary drug transporters and metabolizing enzymes is crucial for comprehending efficient drug exposure and clearance processes within the lungs. These processes are intricately linked to both local and systemic pharmacokinetics and pharmacodynamics of drugs. This review aims to provide a comprehensive overview of the literature on lung transporters and metabolizing enzymes while exploring their roles in exogenous and endogenous substance disposition. Additionally, we identify and discuss the principal challenges in this area of research, providing a foundation for future investigations aimed at optimizing inhaled drug administration. Moving forward, it is imperative that future research endeavors to focus on refining and validating in vitro and ex vivo models to more accurately mimic the human respiratory system. Such advancements will enhance our understanding of drug processing in different pathological states and facilitate the discovery of novel approaches for investigating lung-specific drug transporters and metabolizing enzymes. This deeper insight will be crucial in developing more effective and targeted therapies for respiratory diseases, ultimately leading to improved patient outcomes.
引用
收藏
页数:24
相关论文
共 50 条
  • [21] Myriad Molecules to Overcome Efflux Drug Transporters and Drug-Metabolizing Enzymes: A Journey from Synthetic to Natural
    Mittal, Karan
    Patadia, Riddhish
    Vora, Chintan
    Mashru, Rajashree C.
    CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2015, 32 (05): : 441 - 460
  • [22] Potential Risks Resulting from Fruit/Vegetable-Drug Interactions: Effects on Drug-Metabolizing Enzymes and Drug Transporters
    Rodriguez-Fragoso, Lourdes
    Luis Martinez-Arismendi, Jose
    Orozco-Bustos, Danae
    Reyes-Esparza, Jorge
    Torres, Eliseo
    Burchiel, Scott W.
    JOURNAL OF FOOD SCIENCE, 2011, 76 (04) : R112 - R124
  • [23] Herb-drug Interactions Involving Drug Metabolizing Enzymes and Transporters
    Liu, Chang-Xiao
    Yi, Xiu-Lin
    Si, Duan-Yun
    Xiao, Xue-Feng
    He, Xin
    Li, Ya-Zhuo
    CURRENT DRUG METABOLISM, 2011, 12 (09) : 835 - 849
  • [24] Rhinacanthin-C Mediated Herb-Drug Interactions with Drug Transporters and Phase I Drug-Metabolizing Enzymes
    Dunkoksung, Wilasinee
    Vardhanabhuti, Nontima
    Siripong, Pongpun
    Jianmongkol, Suree
    DRUG METABOLISM AND DISPOSITION, 2019, 47 (10) : 1040 - 1049
  • [25] Gene expression profiles of drug-metabolizing enzymes and transporters with an overexpression of hepatocyte growth factor
    Kakizaki, Satoru
    Yamazaki, Yuichi
    Kosone, Takashi
    Horigichi, Norio
    Sohara, Naondo
    Sato, Ken
    Takagi, Hitoshi
    Yoshinari, Kouichi
    Mori, Masatomo
    LIVER INTERNATIONAL, 2007, 27 (01) : 109 - 119
  • [26] Induction of drug-metabolizing enzymes and transporters in human bronchial epithelial cells by beclomethasone dipropionate
    Kuzuya, Y
    Adachi, T
    Hara, H
    Anan, A
    Izuhara, K
    Nagai, H
    IUBMB LIFE, 2004, 56 (06) : 355 - 359
  • [27] Quantitative Proteomics of Hepatic Drug-Metabolizing Enzymes and Transporters in Patients with Colorectal Cancer Metastasis
    Vasilogianni, Areti-Maria
    Al-Majdoub, Zubida M.
    Achour, Brahim
    Annie Peters, Sheila
    Barber, Jill
    Rostami-Hodjegan, Amin
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 112 (03) : 699 - 710
  • [28] Non-uniformity of Changes in Drug-Metabolizing Enzymes and Transporters in Liver Cirrhosis: Implications for Drug Dosage Adjustment
    El-Khateeb, Eman
    Achour, Brahim
    Al-Majdoub, Zubida M.
    Barber, Jill
    Rostami-Hodjegan, Amin
    MOLECULAR PHARMACEUTICS, 2021, 18 (09) : 3563 - 3577
  • [29] The ontogeny of drug metabolizing enzymes and transporters in the rat
    de Zwart, Loeckie
    Scholten, Martijn
    Monbaliu, Johan G.
    Annaert, Pieter P.
    Van Houdt, Jos M.
    Van den Wyngaert, Ilse
    De Schaepdrijver, Luc M.
    Bailey, Graham P.
    Coogan, Timothy P.
    Coussement, Werner C.
    Mannens, Geert S.
    REPRODUCTIVE TOXICOLOGY, 2008, 26 (3-4) : 220 - 230
  • [30] Alterations of drug-metabolizing enzymes and transporters under diabetic conditions: what is the potential clinical significance?
    Chen, Feng
    Li, De-Yi
    Zhang, Bo
    Sun, Jie-Yu
    Sun, Fang
    Ji, Xing
    Qiu, Jin-Chun
    Parker, Robert B.
    Laizure, S. Casey
    Xu, Jing
    DRUG METABOLISM REVIEWS, 2018, 50 (03) : 369 - 397